Financial Counselors Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,789
Closed -$302K 514
2022
Q2
$302K Buy
3,789
+714
+23% +$67.6K 0.01% 421
2022
Q1
$324K Buy
3,075
+253
+9% +$24.7K 0.01% 415
2021
Q4
$304K Buy
2,822
+74
+3% +$8.07K 0.01% 422
2021
Q3
$301K Buy
+2,748
New +$285K 0.01% 449

Other funds holding HZNP

Financial Counselors Inc's HZNP Position: Q3 2022 in Review

Financial Counselors Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 3,789 shares — an estimated $302K sold.

Financial Counselors Inc first reported a position in HZNP in Q3 2021 and held it in 4 quarters. The position peaked at $324K in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Financial Counselors Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Financial Counselors Inc sold 3,789 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $302K.
  • Financial Counselors Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 4 quarters.
  • Financial Counselors Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $324K in Q1 2022.
  • 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Financial Counselors Inc's 13F filing for Q3 2022, filed 1 Nov 2022.